At the same time, MDM2 is also a bridge between two tumor suppressors, p53 and Rb [44,45,46], which also suggested that inhibitors acting on CDK affect MDM2, which in turn exerts some antitumor effects through p53. Here, TP53 is linked to neoplasm.